Cover Image


Drug Self-Administration to 2022

出版商 Greystone Research Associates 商品編碼 228362
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
藥物自我施打市場:藥物、適應、市場及預測 Drug Self-Administration to 2022
出版日期: 2015年01月01日 內容資訊: 英文




  • 進化的藥物開發與市場因素
  • 管理護理與處方趨勢
  • 藥物自我施打的需求因素
  • 慢性疾病和自我施打
  • 生物製藥的增加
  • 通知設備技術與演進


  • 自我施打注射型產品
    • 市場部門的動態
    • 預填充式注射器(PFS)
      • 玻璃製
      • 塑膠製
    • 自行注射器
    • 筆型注射器
      • 再利用型
      • 拋棄式型
    • 無針注射器 (NFI)
      • 競爭的NFI治療市場區隔
      • NFI製造商簡介
  • 自我施打吸入型產品
    • 市場部門的動態
    • 上氣道市場
    • 全身/肺深部市場
    • 吸入技術和市場預測
    • 吸入型產品部門
      • 乾粉吸入劑
      • 定量吸入器
      • 噴霧器
    • 性能因素
    • 生物利用性
    • 給藥的再現性
    • 活性化合物的穩定性
  • 經皮給藥產品
    • 市場部門的動態
    • 處方藥貼片的設計與技術
    • 主動運輸貼片技術
    • 處方藥貼片的發展要素
    • 主要的經皮治療市場
    • 經皮藥物的主要企業簡介


  • ADHD
  • 抗凝血劑
  • 關節炎
  • 氣喘/慢性阻塞性肺病
  • 心臟血管
  • 避孕
  • 囊狀纖維化症
  • 糖尿病
  • 造血劑
  • 肝炎
  • 荷爾蒙治療/補充
  • 多發性硬化症
  • 神經疾病
  • 骨質疏鬆症
  • 疼痛管理
  • 乾癬
  • 性的健康


Product Code: DSA345R

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs. These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration.


  • Provides detailed analysis of drug self-administration market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration
  • Charts product data, market share, and forecasts to 2022
  • Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table of Contents

Executive Summary

Drug Market Dynamics

  • Evolving Drug Development and Market Factors
  • Managed Care and Prescribing Trends
  • Drug Self-Administration Demand Factors
    • Shifting Patient Demographics
    • Chronic Disease and Self-administration
    • Biological Drugs Proliferating
    • Delivery Device Technology & Evolving

Drug Self-Administration Product Segments and Market Drivers

  • Injectable Drug Self-Administration
  • Market Sector Dynamics
  • Prefilled Syringes (PFS)
    • Glass PFS
    • Plastic PFS
    • Autoinjectors
  • Pen Injectors
    • Reusable Pens
    • Disposable Pens
  • Needle-free Injectors (NFI)
    • Competitive NFI Therapeutic Segments
    • Needle-free Company Profiles
  • Inhaled Drug Self-Administration Products
  • Market Sector Dynamics
    • The Upper Respiratory Market
    • The Systemic/Deep Lung Market
  • Inhaler Technology and Market Prospects
    • Inhaler Product Segments
      • Dry Powder Inhalers
      • Metered Dose Inhalers
      • Nebulizers
    • Performance Factors
      • Bioavailability
      • Dose Reproducibility
      • Active Compound Stability
  • Transdermal Drug Products
  • Market Sector Dynamics
  • Prescription Patch Design & Technology
  • Active Transport Patch Technologies
  • Prescription Patch Development Factors
  • Key Transdermal Therapeutic Markets
  • Transdermal Product Company Profiles

Drug Self-Administration - Therapeutic Sector Analysis & Forecasts

  • ADHD
  • Anticoagulants
  • Arthritis
  • Asthma/COPD
  • Cardiovascular
  • Contraception
  • Cystic Fibrosis
  • Diabetes
  • Hematopoietics
  • Hepatitis
  • Hormone Therapy/Replacement
  • Multiple Sclerosis
  • Neurology
  • Osteoporosis
  • Pain Management
  • Psoriasis
  • Sexual Health
Back to Top